![Han Jung](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Han Jung
Corporate Officer/Principal chez Korean Institute of Certified Public Accountants
Postes actifs de Han Jung
Sociétés | Poste | Début | Fin |
---|---|---|---|
Korean Institute of Certified Public Accountants | Corporate Officer/Principal | - | - |
Historique de carrière de Han Jung
Anciens postes connus de Han Jung
Sociétés | Poste | Début | Fin |
---|---|---|---|
Glycostem Therapeutics BV
![]() Glycostem Therapeutics BV BiotechnologyHealth Technology Glycostem Therapeutics BV operates as a life science company which develops cellular immunotherapy and production technology platforms. It develops cellular immunotherapeutic for the treatment of leukemia, lymphomas, and other forms of cancer. The firm provides Prototype NK-cell and NK-cell progenitor cell products for clinical evaluations and intervention studies; and GBGM, a cell survival and minimal cellular delineation in expansion and differentiation experiments. The company was founded by Dirk Groenewegen and Jan van der Hoeven in 2007 and is headquartered in Oss, the Netherlands. | Directeur/Membre du Conseil | - | - |
Statistiques
Internationale
Pays-Bas | 2 |
Corée du Sud | 2 |
Opérationnelle
Director/Board Member | 1 |
Corporate Officer/Principal | 1 |
Sectorielle
Health Technology | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Entreprise privées | 2 |
---|---|
Glycostem Therapeutics BV
![]() Glycostem Therapeutics BV BiotechnologyHealth Technology Glycostem Therapeutics BV operates as a life science company which develops cellular immunotherapy and production technology platforms. It develops cellular immunotherapeutic for the treatment of leukemia, lymphomas, and other forms of cancer. The firm provides Prototype NK-cell and NK-cell progenitor cell products for clinical evaluations and intervention studies; and GBGM, a cell survival and minimal cellular delineation in expansion and differentiation experiments. The company was founded by Dirk Groenewegen and Jan van der Hoeven in 2007 and is headquartered in Oss, the Netherlands. | Health Technology |
Korean Institute of Certified Public Accountants |